FDA scientists push back on RFK Jr.'s peptide plans, longevity investment eyes a record year, and Hevolution expands its research bench Three stories our co-hosts Klaudia Balogh and Elias Arjan broke down on this week's episode: a regulatory standoff over peptides, fresh data on where longevity capital is flowing in 2026, and a grant program that Elias calls a smarter funding model than most of Silicon Valley's
Customizable for Your Brand: These effervescent tablets can be customized to align perfectly with your brands identity
The cumulative antioxidant activity could be very high with the reactivation of the carboxylic groups (e.g., glutathione or enzymes)
Reconstituted stability: 30 days at 2-8C in low-protein-binding polypropylene containers, protected from light
Importantly, information regarding the indications, dosing, frequency, and duration of treatment remains unknown. Theres almost zero basically zero evidence in human trials, Spittler said
NADH and acetylcarnitine NADH and acetylcarnitine are often taken together, and Dr Lapp only uses this for the most severely ill patients and those with the worst brain fog